Guardant Health, Inc. (GH)
After hours:
| Previous Close | 18.26 |
| Open | 18.31 |
| Bid | 17.04 x 700 |
| Ask | 17.15 x 200 |
| Day's Range | 16.94 - 18.45 |
| 52 Week Range | 16.92 - 41.06 |
| Volume | |
| Avg. Volume | 1,991,259 |
| Market Cap | 2.076B |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.28 |
| Earnings Date | May 07, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.29 |
Business WireGuardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
PALO ALTO, Calif., April 03, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from nine studies highlighting advances in methylation-based epigenomic analysis for precision oncology at the 2024 American Association for Cancer Research (AACR) Annual Meeting, April 5-10 in San Diego.
Investor's Business DailyExact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.
Insider Monkey20 Foods To Reduce Cancer Risk
In this article, we will be taking a look at the 2o foods to reduce cancer risk. If you do no want learn about the global and US cancer stats, head straight to the 5 Foods To Reduce Cancer Risk. Global and US Cancer Statistics According to data from the World Cancer Research Fund International, […]
